Passive Biotech

Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology™ Index (the “Underlying Index”).

$19.91

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Nasdaq Biotechnology ETF IBBQ
Fund Size
$50.9 Million
Dividend
1.0%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.78 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.35 Trillion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$447 Billion
Dividend
3.0%
Fees
0.07%
View 1303 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $61 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.9 %
Beta Indicates the relationship between the price performance of a share and the market. 0.6281
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 39.58
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -95.23
Profitable Companies 52
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 219.46
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 8.81
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 7.86
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -27.88
Enterprise Value to Revenue Enterprise value divided by revenue -1134.74
Total Debt to Enterprise Value Total debt divided by enterprise value 0.09
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.342
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1058.43%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -10.78%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.04%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -5.29%

Industries

Healthcare 81.9%
Other 11.5%
Materials 0.7%
Finance 0.4%
N/A 5.6%

Market cap

Micro Cap 1%
Small Cap 10%
Mid Cap 22%
Large Cap 63%
Mega Cap 4%

270 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$7.95 Million
Weight
19.9%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
20.2
Total Investment
$4.08 Million
Weight
10.2%
Amgen Inc. logo

AMGN - Manufacturing

Amgen Inc.

P/E-Ratio
24.1
Total Investment
$3.59 Million
Weight
9.0%
Vertex Pharmaceuticals Inc. logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc.

P/E-Ratio
-110.4
Total Investment
$3.38 Million
Weight
8.5%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$3.03 Million
Weight
7.6%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
12.5
Total Investment
$2.88 Million
Weight
7.2%
AstraZeneca PLC logo

AZN - Health Technology

AstraZeneca PLC

P/E-Ratio
27.2
Total Investment
$1.69 Million
Weight
4.2%
Alnylam Pharmaceuticals, Inc. logo

ALNY - Manufacturing

Alnylam Pharmaceuticals, Inc.

P/E-Ratio
-120.8
Total Investment
$1.21 Million
Weight
3.0%
Biogen Inc. logo

BIIB - Manufacturing

Biogen Inc.

P/E-Ratio
11.7
Total Investment
$780 Thousand
Weight
2.0%
argenx SE logo

ARGX - Manufacturing

argenx SE

P/E-Ratio
49.2
Total Investment
$769 Thousand
Weight
1.9%
Sanofi logo

SNY - Health Technology

Sanofi

P/E-Ratio
18.2
Total Investment
$625 Thousand
Weight
1.6%
Summit Therapeutics Inc. logo

SMMT

Summit Therapeutics Inc.

P/E-Ratio
-73.5
Total Investment
$581 Thousand
Weight
1.5%
Royalty Pharma PLC logo

RPRX - Manufacturing

Royalty Pharma PLC

P/E-Ratio
17.3
Total Investment
$569 Thousand
Weight
1.4%
Insmed Inc. logo

INSM - Manufacturing

Insmed Inc.

P/E-Ratio
-12.8
Total Investment
$556 Thousand
Weight
1.4%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
11.2
Total Investment
$544 Thousand
Weight
1.4%
Incyte Corp. logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp.

P/E-Ratio
537.0
Total Investment
$539 Thousand
Weight
1.4%
Illumina, Inc. logo

ILMN - Manufacturing

Illumina, Inc.

P/E-Ratio
-9.9
Total Investment
$536 Thousand
Weight
1.3%
Intra-Cellular Therapies, Inc. logo

ITCI - Manufacturing

Intra-Cellular Therapies, Inc.

P/E-Ratio
-182.1
Total Investment
$518 Thousand
Weight
1.3%
BioMarin Pharmaceutical Inc. logo

BMRN - Manufacturing

BioMarin Pharmaceutical Inc.

P/E-Ratio
21.5
Total Investment
$517 Thousand
Weight
1.3%
BeiGene, Ltd. logo

BGNE - Manufacturing

BeiGene, Ltd.

P/E-Ratio
-72.1
Total Investment
$459 Thousand
Weight
1.1%
Neurocrine Biosciences, Inc. logo

NBIX - Manufacturing

Neurocrine Biosciences, Inc.

P/E-Ratio
37.7
Total Investment
$458 Thousand
Weight
1.1%
Moderna, Inc. logo

MRNA - Manufacturing

Moderna, Inc.

P/E-Ratio
-2.8
Total Investment
$454 Thousand
Weight
1.1%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
-30.0
Total Investment
$422 Thousand
Weight
1.1%
Exelixis, Inc. logo

EXEL - Professional, Scientific, and Technical Services

Exelixis, Inc.

P/E-Ratio
19.7
Total Investment
$421 Thousand
Weight
1.1%
Viatris Inc. logo

VTRS - Finance and Insurance

Viatris Inc.

P/E-Ratio
-16.5
Total Investment
$420 Thousand
Weight
1.1%